92 related articles for article (PubMed ID: 18396405)
1. Podophyllotoxin directly binds a hinge domain in E2 of HPV and inhibits an E2/E7 interaction in vitro.
Saitoh T; Kuramochi K; Imai T; Takata K; Takehara M; Kobayashi S; Sakaguchi K; Sugawara F
Bioorg Med Chem; 2008 May; 16(10):5815-25. PubMed ID: 18396405
[TBL] [Abstract][Full Text] [Related]
2. The human papillomavirus E7-E2 interaction mechanism in vitro reveals a finely tuned system for modulating available E7 and E2 proteins.
Smal C; Wetzler DE; Dantur KI; Chemes LB; Garcia-Alai MM; Dellarole M; Alonso LG; Gaston K; de Prat-Gay G
Biochemistry; 2009 Dec; 48(50):11939-49. PubMed ID: 19899811
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the E2 DNA-binding domain from human papillomavirus type 16: implications for its DNA binding-site selection mechanism.
Hegde RS; Androphy EJ
J Mol Biol; 1998 Dec; 284(5):1479-89. PubMed ID: 9878365
[TBL] [Abstract][Full Text] [Related]
4. Peptides inhibitory for the transcriptional regulatory function of human papillomavirus E2.
Fujii T; Austin D; Guo D; Srimatkandada S; Wang T; Kubushiro K; Masumoto N; Tsukazaki K; Nozawa S; Deisseroth AB
Clin Cancer Res; 2003 Nov; 9(14):5423-8. PubMed ID: 14614029
[TBL] [Abstract][Full Text] [Related]
5. HPV oncoprotein E6 is a structure-dependent DNA-binding protein that recognizes four-way junctions.
Ristriani T; Masson M; Nominé Y; Laurent C; Lefevre JF; Weiss E; Travé G
J Mol Biol; 2000 Mar; 296(5):1189-203. PubMed ID: 10698626
[TBL] [Abstract][Full Text] [Related]
6. The mitotic chromosome binding activity of the papillomavirus E2 protein correlates with interaction with the cellular chromosomal protein, Brd4.
Baxter MK; McPhillips MG; Ozato K; McBride AA
J Virol; 2005 Apr; 79(8):4806-18. PubMed ID: 15795266
[TBL] [Abstract][Full Text] [Related]
7. Structure of the papillomavirus DNA-tethering complex E2:Brd4 and a peptide that ablates HPV chromosomal association.
Abbate EA; Voitenleitner C; Botchan MR
Mol Cell; 2006 Dec; 24(6):877-89. PubMed ID: 17189190
[TBL] [Abstract][Full Text] [Related]
8. HPV-18 E7 conjugates to c-Myc and mediates its transcriptional activity.
Wang YW; Chang HS; Lin CH; Yu WC
Int J Biochem Cell Biol; 2007; 39(2):402-12. PubMed ID: 17070091
[TBL] [Abstract][Full Text] [Related]
9. Characterization of the papillomavirus alpha(1)E2 peptide unfolded to folded transition upon DNA binding.
Giesel GM; Lima LM; Faber-Barata J; Guimarães JA; Verli H
FEBS Lett; 2008 Oct; 582(25-26):3619-24. PubMed ID: 18834883
[TBL] [Abstract][Full Text] [Related]
10. Purification and characterisation of the E7 oncoproteins of the high-risk human papillomavirus types 16 and 18.
Fiedler M; Campo-Fernández B; Laich A; Moser B; Stöckl P; Jansen-Dürr P; Zwerschke W
J Virol Methods; 2006 Jun; 134(1-2):30-5. PubMed ID: 16384614
[TBL] [Abstract][Full Text] [Related]
11. Phage display for site-specific immunization and characterization of high-risk human papillomavirus specific E7 monoclonal antibodies.
Lidqvist M; Nilsson O; Holmgren J; Hall C; Fermér C
J Immunol Methods; 2008 Sep; 337(2):88-96. PubMed ID: 18606164
[TBL] [Abstract][Full Text] [Related]
12. Interactions of the cellular CCAAT displacement protein and human papillomavirus E2 protein with the viral origin of replication can regulate DNA replication.
Narahari J; Fisk JC; Melendy T; Roman A
Virology; 2006 Jul; 350(2):302-11. PubMed ID: 16529788
[TBL] [Abstract][Full Text] [Related]
13. Search for cellular partners of human papillomavirus type 16 E2 protein.
Olejnik-Schmidt AK; Schmidt MT; Kedzia W; Goździcka-Józefiak A
Arch Virol; 2008; 153(5):983-90. PubMed ID: 18305892
[TBL] [Abstract][Full Text] [Related]
14. Viral interaction: a possible contributing factor in head and neck cancer progression.
Underbrink MP; Hoskins SL; Pou AM; Albrecht T
Acta Otolaryngol; 2008; 128(12):1361-9. PubMed ID: 18607925
[TBL] [Abstract][Full Text] [Related]
15. Structural and thermodynamic basis for the enhanced transcriptional control by the human papillomavirus strain-16 E2 protein.
Cicero DO; Nadra AD; Eliseo T; Dellarole M; Paci M; de Prat-Gay G
Biochemistry; 2006 May; 45(21):6551-60. PubMed ID: 16716065
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
[TBL] [Abstract][Full Text] [Related]
17. Applying linear interaction energy method for binding affinity calculations of podophyllotoxin analogues with tubulin using continuum solvent model and prediction of cytotoxic activity.
Alam MA; Naik PK
J Mol Graph Model; 2009; 27(8):930-43. PubMed ID: 19286405
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the binding site for inhibitors of the HPV11 E1-E2 protein interaction on the E2 transactivation domain by photoaffinity labeling and mass spectrometry.
Davidson W; McGibbon GA; White PW; Yoakim C; Hopkins JL; Guse I; Hambly DM; Frego L; Ogilvie WW; Lavallée P; Archambault J
Anal Chem; 2004 Apr; 76(7):2095-102. PubMed ID: 15053675
[TBL] [Abstract][Full Text] [Related]
19. Screening of paclitaxel-binding molecules from a library of random peptides displayed on T7 phage particles using paclitaxel-photoimmobilized resin.
Aoki S; Morohashi K; Sunoki T; Kuramochi K; Kobayashi S; Sugawara F
Bioconjug Chem; 2007; 18(6):1981-6. PubMed ID: 17979224
[TBL] [Abstract][Full Text] [Related]
20. A viral DNA-binding domain elicits anti-DNA antibodies of different specificities.
Cerutti ML; Zarebski LM; de Prat Gay G; Goldbaum FA
Mol Immunol; 2005 Feb; 42(3):327-33. PubMed ID: 15589321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
